Related Experiment Videos

Activation of Ca(2+)-sensitive cytosolic phospholipase A2 (cPLA2) in human platelets

R M Kramer¹, E F Roberts, J A Jakubowski

¹Lilly Research Laboratories, Indianapolis, IN 46285, USA.

Advances in Experimental Medicine and Biology

|January 1, 1997

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Induction of Diabetes Abolishes the Antithrombotic Effect of Clopidogrel in Apolipoprotein E-Deficient Mice.

TH open : companion journal to thrombosis and haemostasis·2019

Reversibility of platelet P2Y12 inhibition by platelet supplementation: ex vivo and in vitro comparisons of prasugrel, clopidogrel and ticagrelor.

Journal of thrombosis and haemostasis : JTH·2018

Incomplete reversibility of platelet inhibition following prolonged exposure to ticagrelor.

Journal of thrombosis and haemostasis : JTH·2017

The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease.

Thrombosis and haemostasis·2014

Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients. High on-treatment platelet reactivity analysis of the TRIPLET trial.

Thrombosis and haemostasis·2014

Detecting a thienopyridine effect by platelet reactivity assessment and its implications for risk stratification.

Journal of thrombosis and haemostasis : JTH·2014

See all related articles